Remove Hospitals Remove Immunization Remove Magazine
article thumbnail

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19

Pharma Mirror

The ACTT-3 trial assessed the efficacy and safety of interferon beta-1a plus remdesivir compared to remdesivir alone in hospitalized adults with COVID-19. Preliminary data from prior small studies had suggested a potential benefit of interferon beta-1a, a natural antiviral component of the immune system, for COVID-19 patients.

article thumbnail

Digital passports – could they help life return to normal?

pharmaphorum

There is also the potential for the technology to be used to allow other industries such as hospitality and sport to restart, by ensuring those attending mass gatherings are free of the virus. But could digital immunity passports be the answer? Our focus should be on getting people vaccinated. About the author.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

If we work closely with government stakeholders and possibly collaborate on developing innovative access schemes for rare diseases, cancers, immune and inflammatory disorders, we can encourage greater participation by established biopharmas and stimulate the growth of entrepreneurial local companies in the region.”. About the author.

article thumbnail

How digital pathways are changing healthcare

pharmaphorum

That’s according to Dr Gareth Parkes – a full-time gastroenterologist who co-founded Ampersand Health, which develops digital therapeutics for inflammatory bowel disease (IBD) and other immune mediated inflammatory diseases (IMIDs). Every single hospital has a different process and a different set of forms to fill in.”.

article thumbnail

After a slow start for expensive CAR-T therapies, drug developers revisit oral therapies for blood cancer

pharmaphorum

In the last few years, the first generation of cell therapies has offered a powerful new way of treating blood cancers, with CAR-T technology reprogramming patients’ immune system to fight cancer. This alone causes expense for cash-strapped hospitals and puts pressure on nursing and medical staff while they manage the side effects.

article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

Birthplace: Belén was born in Almansa (Spain) Additional Information: Merck became a significant international participant in immunology, oncology, and immune oncology under her leadership of the Healthcare business. and Banco Bilbao Vizcaya Argentaria S.A " LinkedIn Total experience: 29 yrs. LinkedIn Total experience: 31 yrs.

FDA 40
article thumbnail

Emotional empathy is driving brand equity

pharmaphorum

T-Mobile went into partnership with Verizon, AT&T, and iHeartMedia to give 40,000 phone chargers to hospitals, putting frightened, isolated patients back in touch with loved ones. Brands are contributing in myriad different, relevant and engaging ways. Verizon also donated $2.5